Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
26.69
+0.17 (0.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
Zymeworks Employees
As of December 31, 2024, Zymeworks had 286 total employees, including 280 full-time and 6 part-time employees. The number of employees increased by 8 or 2.88% compared to the previous year.
Employees
286
Change (1Y)
8
Growth (1Y)
2.88%
Revenue / Employee
$470,213
Profits / Employee
-$221,773
Market Cap
2.00B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZYME News
- 2 days ago - Zymeworks Inc. (ZYME) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 days ago - Zymeworks Announces Participation in Upcoming Conferences - GlobeNewsWire
- 11 days ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 14 days ago - Zymeworks: Adjusting My Levels After Ziihera's Phase III Data For GEA - Seeking Alpha
- 16 days ago - Zymeworks: A Lot Of Moving Parts - Seeking Alpha
- 17 days ago - Zymeworks Inc. (ZYME) Shareholder/Analyst Call Transcript - Seeking Alpha
- 18 days ago - Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer - GlobeNewsWire
- 18 days ago - Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets - GlobeNewsWire